Roxadustat and thyroid-stimulating hormone suppression

Hypoxia-inducible factor prolyl-hydroxylase inhibitors belong to a new class of orally administered drugs for treating anemia in patients with chronic kidney disease (CKD). The prevalence of hypothyroidism is disproportionately high in patients with CKD on hemodialysis. We report a rapid suppression...

Descripción completa

Detalles Bibliográficos
Autores principales: Tokuyama, Atsuyuki, Kadoya, Hiroyuki, Obata, Atsushi, Obata, Takahiro, Sasaki, Tamaki, Kashihara, Naoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Exceptional Cases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087136/
https://www.ncbi.nlm.nih.gov/pubmed/33959275
http://dx.doi.org/10.1093/ckj/sfab007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087136/
https://www.ncbi.nlm.nih.gov/pubmed/33959275
http://dx.doi.org/10.1093/ckj/sfab007

Ejemplares similares